What is Biocon Ltd. Quarterly Revenue?

Biocon Ltd. Quarterly Revenue Biocon Jun-2026 Quarterly Revenue is Rs 689 Cr which is growth of 15.2% YoY.

What is Biocon Ltd. Quarterly Net Profit?

Biocon Ltd. Quarterly Net Profit Biocon Jun-2026 Quarterly Net Profit is Rs 52 Cr which is growth of 728.9% YoY.

What is Biocon Ltd. Annual Revenue?

Biocon Ltd. Annual Revenue Biocon Mar-2026 Annual Revenue is Rs 2,666 Cr which is growth of 7.3% YoY.

What is Biocon Ltd. Annual Net Profit?

Biocon Ltd. Annual Net Profit Biocon Mar-2026 Annual Net Profit is Rs 37 Cr which is growth of -93.9% YoY.

What is Biocon Ltd. Total Shareholders Fund?

Biocon Ltd. Total Shareholders Fund Biocon Mar-2026 Total Shareholders Fund is Rs 27,080 Cr which is growth of 135.0% YoY.

What is Biocon Ltd. Total Assets?

Biocon Ltd. Total Assets Biocon Mar-2026 Total Assets is Rs 29,271 Cr which is growth of 87.4% YoY.

What is Biocon Ltd. Book Value Per Share?

Biocon Ltd. Book Value Per Share Biocon Mar-2026 Book Value Per Share is 167 Rs which is growth of 74.0% YoY.

What is Biocon Ltd. ROE?

Biocon Ltd. ROE Biocon Mar-2026 ROE is 0% which is growth of 5.2% YoY.

What is Biocon Ltd. Cash From Operating Activity?

Biocon Ltd. Cash From Operating Activity Biocon Mar-2026 Cash From Operating Activity is Rs -180 Cr which is growth of -128.9% YoY.

What is Biocon Ltd. Net Cash Flow?

Biocon Ltd. Net Cash Flow Biocon Mar-2026 Net Cash Flow is Rs -160 Cr which is growth of -225.9% YoY.

Biocon Ltd.

NSE: BIOCON | BSE: 532523

Mid-range Performer

Download real time

Clinical Trials Patent Approvals

-0.10(-0.03%)

52W Low on Oct 23, 2026

2.1M

NSE+BSE Volume

NSE 30 Oct, 2026 3:31 PM (IST)

Portfolio

Alert

My Notes

Board Meeting

The next board meeting for Biocon is on 04 Nov 2026 for the purpose of Quarterly Results See details

Biocon quarterly and annual financials: results, revenue, profit, P&L, balance sheet, cash flow, financial ratios, revenue mix, peer comparison, and financial documents

View Charts

Forecaster Analyst Estimates for Biocon share price target, revenues, EPS, net income and more

Biocon quarterly results: revenue, profit, and P&L – 13 quarter history

Nested row level

Base Level

Reporting Type

Standalone

Cell Data

Actual

Table Settings

YoY & New to Old

Nested row level

Base Level

Export

POSITIVE
Quarterly Revenue Biocon Jun-2026 Quarterly Revenue is Rs 689 Cr which is growth of 15.2% YoY.
POSITIVE
Quarterly Net Profit Biocon Jun-2026 Quarterly Net Profit is Rs 52 Cr which is growth of 728.9% YoY.

Biocon Ltd., Quarterly, standalone, All financials are in INR Cr and price data in INR
Indicator	Jun '26	Mar '26	Dec '25	Sep '25	Jun '25	Mar '25	Dec '24	Sep '24	Jun '24	Mar '24	Dec '23	Sep '23	Jun '23
TOTAL_SR_Q Total Rev. ⌄	689.3	654.5	696.1	717.1	598.4	706.5	627	598.9	552.5	571.5	611.3	588.3	549.2
SR_Q Operating Rev.	624.5	604.7	621.3	583.3	537.1	643.8	562.8	525.4	510.6	532.6	562.8	518.7	513.2
OI_Q Other Income	64.8	49.8	74.8	133.8	61.3	62.7	64.2	73.5	41.9	38.9	48.5	69.6	36
OEXPNS_Q Operating Exp.	563.7	525.4	548	530.4	516.5	581.8	531.5	487.8	465.7	480.4	491.5	451.5	441.2
OEXPNS_Q Operating Exp.	563.7	525.4	548	530.4	516.5	581.8	531.5	487.8	465.7	480.4	491.5	451.5	441.2
OP_Q Operating Profit	60.8	79.3	73.3	52.9	20.6	62	31.3	37.6	44.9	52.2	71.3	67.2	72
OPMPCT_Q Operating Profit Margin %	9.74%	13.11%	11.80%	9.07%	3.84%	9.63%	5.56%	7.16%	8.79%	9.80%	12.67%	12.96%	14.03%
DEP_Q Depr.	38.4	36.2	34	33.8	33.3	33	33.8	30.5	30.5	29.8	30.9	30.6	29.8
INT_Q Interest	17.3	16.7	2.3	67.2	56.2	56.7	65.3	59.7	55.2	39.5	56	55	48.3
PBT_Q Profit Before Tax	69.9	57.4	-84.5	85.7	-7.6	35	603.9	20.9	1.1	21.8	32.9	46	49.6
TAX_Q Tax	17.7	6.4	-8.1	14.8	0.7	13.8	19.9	17.7	0.2	7.8	8.9	11.3	3
NP_Q Net Profit	52.2	51	-76.4	70.9	-8.3	21.2	584	3.2	0.9	14	24	34.7	46.6
EPS_adj_Q EPS Adj. latest	0.3	0.3	-0.5	0.4	-0.1	0.1	3.6	0	0	0.1	0.2	0.2	0.3
NP_TTM Net profit TTM	97.7	37.2	7.4	667.8	600.1	609.3	602.1	42.1	73.6	119.3	1,916.1	1,927.3	2,880.1
EPS_TTM Basic EPS TTM	0.6	0.2	0.1	5	4.5	5.1	5	0.4	0.6	1	16	16.1	24
earnings_transcripts Earnings Transcripts
ai_summary AI Summary
results_pdf Results PDF
result_notes Result Notes	Notes	Notes	Notes	Notes	Notes		Notes	Notes	Notes	Notes	Notes	Notes	Notes

*All financials are in INR Cr and price data in INR

Add metric to table

Search...

Biocon competitor comparison and performance snapshot within industry

Biocon revenue mix: sales, profit, and capital employed breakups by segment

Biocon annual results: revenue, profit, P&L, and margins as of Mar 2026 – 11 year history

Nested row level

Base Level

Reporting Type

Standalone

Cell Data

Actual

Table Settings

YoY & New to Old

CAGR Columns

Select...

Nested row level

Base Level

Export

POSITIVE
Annual Revenue Biocon Mar-2026 Annual Revenue is Rs 2,666 Cr which is growth of 7.3% YoY.
NEGATIVE
Annual Net Profit Biocon Mar-2026 Annual Net Profit is Rs 37 Cr which is growth of -93.9% YoY.

Biocon Ltd., Annual, standalone, All financials are in INR Cr and price data in INR
Indicator	CAGR 3 Yrs	CAGR 5 Yrs	TTM	Mar '26	Mar '25	Mar '24	Mar '23	Mar '22	Mar '21	Mar '20	Mar '19	Mar '18	Mar '17	Mar '16
SR_A Total Rev. Ann. ⌄	5.6%	4.1%	2,757	2,666.1	2,484.9	2,320.3	2,264.3	1,925.4	2,178.6	2,190.1	3,002.2	2,543.9	2,686.7	2,474.9
TotalOperatingRevenues_A Operating Rev. Ann.	5.6%	3%	2,433.8	2,346.4	2,242.6	2,127.3	1,992.9	1,738.2	2,028.4	1,988.4	2,884.7	2,419.2	2,587.9	2,301.8
OI_A Other Income Ann.	5.6%	16.3%	323.2	319.7	242.3	193	271.4	187.2	150.2	201.7	117.5	124.7	98.8	173.1
OEXPNS_A Operating Exp. Ann.	2.5%	4.3%	2,167.5	2,120.3	2,066.8	1,864.6	1,969.4	1,677.1	1,715.9	1,702.4	2,499.1	2,101	1,996.1	1,884.8
OEXPNS_A Operating Exp. Ann.	2.5%	4.3%	2,167.5	2,120.3	2,066.8	1,864.6	1,969.4	1,677.1	1,715.9	1,702.4	2,499.1	2,101	1,996.1	1,884.8
OP_A Operating Profit Ann.	112.7%	-6.3%	266.3	226.1	175.8	262.7	23.5	61.1	312.5	286	385.6	318.2	591.8	417
OPMPCT_A OPM Ann. %	101.3%	-10%		8.48%	7.07%	11.32%	1.04%	3.17%	14.34%	13.06%	12.84%	12.51%	22.03%	16.85%
TotalExpenses_A Total Exp. Ann. ⌄	3.6%	5.7%		2,400	2,431.5	2,184.5	2,155.9	1,785.7	1,819.8	1,801.6	2,648.8	2,238.1	2,150.5	2,026.4
OtherExpenses_A Other Exp. Ann.	1.8%	2.1%	592.2	584.8	547.8	487.6	554.1	501.2	527.4	529.9	732	643	595.9	575.4
EmployeeBenefitExpenses_A Employee Exp. Ann.	2.5%	3.7%	474.6	467.2	501.3	452.3	433.8	367.7	390.2	344.8	510.3	408.6	365	321.9
CostOfPowerPurchased_A Cost Of Power Purchased Ann.	-	-
CostOfFuel_A Cost Of Fuel Ann.	-	-
EBIDT_A EBITDA Ann.	22.8%	3.4%		545.8	418.1	455.7	294.9	248.3	462.7	487.7	503.1	442.9	690.6	590.1
EBIDTPCT_A EBITDA Ann. margin %	16.3%	-0.7%		20.47%	16.83%	19.64%	13.02%	12.90%	21.24%	22.27%	16.76%	17.41%	25.70%	23.84%
INT_A Interest Ann.	27%	223.8%	103.5	142.4	236.9	198.8	69.6	0.4	0.4	1.2	2.6	1	3.8	1.9
DEP_A Depr.	5.5%	5.8%	142.4	137.3	127.8	121.1	116.9	108.2	103.5	98	147.1	136.1	150.6	139.7
PBT_A PBT Ann.	-74.2%	-32.3%	128.5	51	660.9	150.3	2,971.2	139.7	358.8	548.2	552.1	305.8	536.2	559.4
TAX_A Tax Ann.	-51.7%	-29.3%	30.8	13.8	51.6	31	122.8	53.6	78.3	111.9	59.4	67.3	16.9	190.8
PAT_A PAT Before ExtraOrdinary Items Ann. ⌄	-76.5%	-33.2%		37.2	609.3	119.3	2,848.4	86.1	280.5	436.3	492.7	238.5	519.3	368.6
IncomeMinorityInterest_A Minority Interest Income Ann.	-	-		-	-	-	-	-	-	-	-	-	-	-
NP_A Net Profit Ann.	-76.5%	-33.2%	97.7	37.2	609.3	119.3	2,848.4	86.1	280.5	440.9	492.7	238.5	519.3	368.6
NETPCT_A NPM Ann. %	-77.7%	-35.2%		1.58%	27.16%	5.60%	142.92%	4.95%	13.82%	22.17%	17.07%	9.85%	20.06%	16.01%
EPS_adj_A EPS Adj. latest Ann.	-77.5%	-34.8%		0.2	3.7	0.7	17.5	0.5	1.7	2.7	3	1.5	3.2	2.3
result_notes Result Notes				Notes		Notes	Notes	Notes	Notes	Notes	Notes	Notes	Notes
Annual_Reports Annual Reports

*All financials are in INR Cr and price data in INR

Add metric to table

Search...

Total Rev. Ann.

1Y CHG

7.3%

2Y CAGR

7.2%

3Y CAGR

5.6%

5Y CAGR

4.1%

7Y CAGR

-1.7%

10Y CAGR

0.7%

Total Revenue Annual growth is higher than historical averages.

Net Profit Ann.

1Y CHG

-93.9%

2Y CAGR

-44.2%

3Y CAGR

-76.5%

5Y CAGR

-33.2%

7Y CAGR

-30.9%

10Y CAGR

-20.5%

Net Profit Annual is falling faster than historical averages.

Operating Exp. Ann.

1Y CHG

2.6%

2Y CAGR

6.6%

3Y CAGR

2.5%

5Y CAGR

4.3%

7Y CAGR

-2.3%

10Y CAGR

1.2%

Operating Expenses Annual Cr growth is stable compared to historical averages.

Biocon balance sheet as of Mar 2026: assets, liabilities, reserves, and borrowings – 11 year history

Nested row level

Base Level

Reporting Type

Standalone

Cell Data

Actual

Table Settings

YoY & New to Old

CAGR Columns

Select...

Nested row level

Base Level

Export

POSITIVE
Total Shareholders Fund Biocon Mar-2026 Total Shareholders Fund is Rs 27,080 Cr which is growth of 135.0% YoY.
POSITIVE
Total Assets Biocon Mar-2026 Total Assets is Rs 29,271 Cr which is growth of 87.4% YoY.

Biocon Ltd., Balance Sheet, standalone, All financials are in INR Cr and price data in INR
Indicator	CAGR 3 Yrs	CAGR 5 Yrs	Mar '26	Mar '25	Mar '24	Mar '23	Mar '22	Mar '21	Mar '20	Mar '19	Mar '18	Mar '17	Mar '16
TotalShareHoldersFunds_A Total ShareHolders Funds Ann. ⌄	35.4%	27.9%	27,079.8	11,524.4	10,912.3	10,916	8,092.9	7,907.1	7,537.3	7,115.4	6,738.6	6,541.1	5,996.6
EQCAP_A Equity Share Capital Ann.	10.5%	6.2%	810.5	600.3	600.3	600.3	600.3	600	600	300	300	100	100
TotalShareCapital_A Total Share Capital Ann.	10.5%	6.2%	810.5	600.3	600.3	600.3	600.3	600	600	300	300	100	100
ReservesAndSurplus_A Reserves Plus Surplus Ann.	36.6%	29.2%	26,268.4	10,923.2	10,311.1	10,314.8	7,491.7	7,306.2	6,936.4	6,814.5	6,437.7	6,440.2	5,895.7
TotalReservesAndSurplus_A Total Reserves Plus Surplus Ann.	36.6%	29.2%	26,269.3	10,924.1	10,312	10,315.7	7,492.6	7,307.1	6,937.3	6,815.4	6,438.6	6,441.1	5,896.6
LiabilityMinorityInterest_A Minority Interest Liability Ann.	-	-	-	-	-	-	-	-	-	-	-	-	-
TotalNonCurrentLiabilities_A Total Non Current Liabilities Ann. ⌄	-45.8%	14.1%	225.4	2,359.5	2,164.7	1,415.9	185.2	116.4	45.5	131.7	156.7	222.6	238.9
DeferredTaxLiabilities_A Deferred Tax Liabilities Ann.	-	-	6.9	13.6									0.9
OtherLongTermLiabilities_A Other LongTerm Liabilities Ann.	-11.3%	-6.4%	64.8	61.1	95.6	92.8	83.7	90.1	23.4	105.5	72.3	76.9	92
CL_A Total Current Liabilities Ann. ⌄	41.2%	29%	1,965.4	1,737.2	691.2	698	590.9	550.2	728	993.3	831.6	705.2	862.6
TradePayables_A Trade Payables Ann.	6.6%	9.6%	588.8	814.4	447.6	485.9	380.9	372	521.2	643.9	579.7	450.5	394.4
OtherCurrentLiabilities_A Other Current Liabilities Ann.	15%	12.8%	279.4	268.8	211.5	183.9	185.2	152.7	182.4	294.6	220.3	222.7	214.2
ShortTermProvisions_A ST Provisions Ann.	12.7%	9.6%	40.4	34.5	32.1	28.2	24.8	25.5	24.4	54.8	31.6	32	28.5
TL_A Total Capital Plus Liabilities Ann.	31%	27.8%	29,270.6	15,621.1	13,768.2	13,029.9	8,869	8,573.7	8,310.8	8,240.4	7,726.9	7,468.9	7,098.1
FixedAssets_A Fixed Assets Ann. ⌄	13.8%	14.5%	1,922.2	1,814.8	1,518	1,304.9	1,155.1	977.3	945.1	1,355.6	1,221.1	1,178.8	1,110
TangibleAssets_A Tangible Assets Ann.	14.4%	13.3%	1,320.5	1,045.3	885.4	882.7	784.3	708.2	698.6	1,029.1	834.1	864.9	859.6
IntangibleAssets_A Intangible Assets Ann.	-14.1%	-12.3%	10.6	14.2	15	16.7	20.4	20.4	22.1	30.1	24.7	29.2	34.2
CapitalWorkInProgress_A Capital Work In Progress Ann.	16.7%	26%	523.2	686.7	545	328.9	270.3	164.6	151.9	254.5	318.5	240.8	172.3
TotalNonCurrentAssets_A Total Non Current Assets Ann. ⌄	37.1%	33.3%	26,982.6	13,450.9	11,008.2	10,463.9	6,466.8	6,404.4	6,227.1	5,794	5,669.2	5,090.4	4,727
NonCurrentInvestments_A Non Current Investments Ann.	40.5%	37.4%	24,805.6	11,382.6	9,255.6	8,949.8	5,017.8	5,073.4	4,814	3,902.8	3,745.2	3,363.5	3,210.6
DeferredTaxAssets_A Deferred Tax Assets Ann.	-	-			7.4	22.8	120	146.4	179.5	201.9	102.2	105.4
LongTermLoansAndAdvances_A LT Loans Plus Advances Ann.	-	-					19		156.7	106.6	281.7	192.3	158.4
OtherNonCurrentAssets_A Other Non Current Assets Ann.	11%	4.2%	254.8	253.5	227.2	186.4	154.9	207.3	131.8	227.1	319	250.4	248
CA_A Total Current Assets Ann. ⌄	-3.8%	1.1%	2,288	2,170.2	2,760	2,566	2,402.2	2,169.3	2,083.7	2,446.4	2,057.7	2,378.5	2,371.1
CurrentInvestments_A Current Investments Ann.	-18.8%	-12.7%	172.1		62.9	320.9	262.2	339.3	138.8	113.4	453.8	524.7	598.3
TradeReceivables_A Trade Receivables Ann.	15.1%	11.3%	1,003.1	829.4	1,048.1	658	700.6	588	573.2	901.8	739.9	798.2	503.8
CashAndCashEquivalents_A Cash Plus Cash Equivalents Ann.	-49.7%	-31.3%	91.7	249.8	585.7	720.3	689.3	601.2	375.3	356	196.9	382.9	643
ShortTermLoansAndAdvances_A ST Loans Plus Advances Ann.	-	-					22.3		100.6	91.8
OtherCurrentAssets_A Other Current Assets Ann.	-21.9%	-7%	146	254.7	398.6	306.7	186.3	209.9	361.1	181.5	105.4	133.1	121.4
TA_A Total Assets Ann.	31%	27.8%	29,270.6	15,621.1	13,768.2	13,029.9	8,869	8,573.7	8,310.8	8,240.4	7,726.9	7,468.9	7,098.1
ContingentLiabilities_A Contingent Liabilities plus Commitments Ann.	11.1%	-10%	1,035.4	1,081.4	1,125.3	754.8	638.3	1,749.6	2,203.7	1,932.8	1,797.7	1,708.6	1,644.3
BonusEquityShareCapital_A Bonus Equity Share Capital Ann.	0%	0%	593.5	593.5	593.5	593.5	593.5	593.5	593.5	293.5	293.5	93.5	93.5
NonCurrentInvestmentsUnquotedBookValue_A Non Current Investments Unquoted Book Value Ann.	49.1%	56.7%	22,794.2	9,377.4	7,185	6,878.3	2,359.7	2,411.8	2,149.8	1,236.8	1,022	640.3	487.2
CurrentInvestmentsUnquotedBookValue_A Current Investments Unquoted Book Value Ann.	-	-			62.9	320.9	255	205	80	50	145.9	212	598.3

*All financials are in INR Cr and price data in INR

Add metric to table

Search...

Total Assets Ann.

1Y CHG

87.4%

2Y CAGR

45.8%

3Y CAGR

31%

5Y CAGR

27.8%

7Y CAGR

19.9%

10Y CAGR

15.2%

Total Assets Annual growth is higher than historical averages.

Total Current Liabilities Ann.

1Y CHG

13.1%

2Y CAGR

68.6%

3Y CAGR

41.2%

5Y CAGR

29%

7Y CAGR

10.2%

10Y CAGR

8.6%

Total Current Liabilities Annual Cr growth is stable compared to historical averages.

Total ShareHolders Funds Ann.

1Y CHG

135%

2Y CAGR

57.5%

3Y CAGR

35.4%

5Y CAGR

27.9%

7Y CAGR

21%

10Y CAGR

16.3%

Total ShareHolders Funds Annual growth is higher than historical averages.

Biocon ROE, ROCE, book value, and debt-to-equity ratio as of Mar 2026 – 11 year history

Nested row level

Base Level

Reporting Type

Standalone

Cell Data

Actual

Table Settings

YoY & New to Old

CAGR Columns

Select...

Nested row level

Base Level

Export

POSITIVE
Book Value Per Share Biocon Mar-2026 Book Value Per Share is 167 Rs which is growth of 74.0% YoY.
POSITIVE
ROE Biocon Mar-2026 ROE is 0% which is growth of 5.2% YoY.

Biocon Ltd., Ratios, standalone, All financials are in INR Cr and price data in INR
Indicator	CAGR 3 Yrs	CAGR 5 Yrs	Mar '26	Mar '25	Mar '24	Mar '23	Mar '22	Mar '21	Mar '20	Mar '19	Mar '18	Mar '17	Mar '16
BVSH_A BVSH Ann.	22.5%	20.5%	167.1	96	90.9	90.9	67.4	65.9	62.8	118.6	112.3	327	299.8
ROA_A RoA Ann. %	-82.4%	-48.4%	0.12%	3.90%	0.86%	21.86%	0.97%	3.27%	5.30%	5.97%	3.08%	6.95%	5.19%
ROE_A ROE Ann. %	-82.9%	-48.4%	0.13%	5.28%	1.09%	26.09%	1.06%	3.54%	5.85%	6.92%	3.53%	7.94%	6.14%
ROCE_A ROCE Ann. %	1.1%	-19.7%	1.49%	2.09%	2.55%	1.44%	1.69%	4.47%	5.13%	4.91%	4.44%	7.98%	7.22%
ProfitabilityHeader Profitability Ratio ⌄
PBDITMargin_A EBITDA Ann. Margin %	16.3%	0.4%	23.26%	18.64%	21.42%	14.79%	14.28%	22.81%	24.52%	17.44%	18.30%	26.68%	25.63%
PBITMargin_A EBIT Ann. Margin %	24.9%	-0.3%	17.40%	12.94%	15.72%	8.93%	8.06%	17.70%	19.59%	12.34%	12.68%	20.86%	19.56%
PBTMargin_A PBT Ann. Margin %	-75.6%	-34.3%	2.17%	29.47%	7.06%	149.08%	8.03%	17.68%	27.56%	19.13%	12.64%	20.71%	24.30%
NETPCT_A NPM Ann. %	-77.7%	-35.2%	1.58%	27.16%	5.60%	142.92%	4.95%	13.82%	22.17%	17.07%	9.85%	20.06%	16.01%
ASETTO_A Asset Turnover Ann. %	-20.6%	-12.9%	0.1	0.2	0.2	0.2	0.2	0.2	0.2	0.4	0.3	0.4	0.4
LiquidityHeader Liquidity Ratio ⌄
CRATIO_A Current Ratio Ann.	-31.3%	-21%	1.2	1.3	4	3.7	4.1	3.9	2.9	2.5	2.5	3.4	2.8
QuickRatio_A Quick Ratio Ann.	-37.7%	-26.2%	0.7	0.8	3	2.9	3.2	3.2	2.1	1.7	1.8	2.6	2.2
DividendPayoutNP_A Dividend Payout to NP Ann.	-	-	2.2	0.1	2.1	0			0.2	0.3	0.7		4.4
EarningRetention_A Earning Retention Ann. %	-	-	-79.56%	90.16%	-50.96%	97.90%			86.37%	85.92%	70.95%		69.97%
CashEarningRetention_A Cash Earning Retention Ann. %	-14.3%	-	61.72%	91.86%	25.09%	97.98%			88.85%	89.16%	81.51%		78.23%
CashEarningRetention_A Cash Earning Retention Ann. %	-14.3%	-	61.72%	91.86%	25.09%	97.98%			88.85%	89.16%	81.51%		78.23%
ValuationHeader Valuation Ratio ⌄
EnterpriseValue_A EnterpriseValue Ann.	32.9%	4.2%	59,552.4	43,585.7	33,163	25,351.8	39,552.7	48,454.8	32,097.4	36,305.4	35,522.3	22,419.5	9,361
EVPerNetSales_A EV Per Net Sales Ann.	26%	1.2%	25.4	19.4	15.6	12.7	22.8	23.9	16.1	12.6	14.7	8.7	4.1
PBV_A Price To Book Value Adjusted	-18.2%	-16.9%	2.12	4.29	3.87	3.87	5.22	5.34	5.6	2.97	3.13	1.08	1.17
EVPerEBITDA_A EV Per EBITDA Ann.	8.3%	0.8%	109.1	104.3	72.8	86	159.3	104.7	65.8	72.2	80.2	32.5	15.9
MarketCapPerSales_A Market Cap Per Sales Ann.	26.2%	0.6%	24.9	18.3	14.9	12.4	23.1	24.2	16.3	12.7	14.7	8.8	4.2
RetentionRatios_A Retention Ratio Ann. %	-	-	-79.56%	90.15%	-50.96%	97.89%			86.36%	85.91%	70.94%		69.96%
EYield_A Earnings Yield Ann.	-	-		0		0.1		0	0	0	0	0	0
DEBT_CE_A Total Debt to Total Equity Ann.			0	0.3	0.2	0.1	0				0	0	0.1

*All financials are in INR Cr and price data in INR

Add metric to table

Search...

ROE Ann. %

1Y CHG

-97.5%

2Y CAGR

-65.5%

3Y CAGR

-82.9%

5Y CAGR

-48.4%

7Y CAGR

-43.3%

10Y CAGR

-32%

ROE Annual % is falling faster than historical averages.

RoA Ann. %

1Y CHG

-96.9%

2Y CAGR

-62.6%

3Y CAGR

-82.4%

5Y CAGR

-48.4%

7Y CAGR

-42.8%

10Y CAGR

-31.4%

RoA Annual % is falling faster than historical averages.

Current Ratio Ann.

1Y CHG

-7.7%

2Y CAGR

-45.2%

3Y CAGR

-31.3%

5Y CAGR

-21%

7Y CAGR

-10%

10Y CAGR

-8.1%

Current Ratio Annual is falling slower than historical averages.

Biocon cash flow: net, operating, investing, and financing flows as of Mar 2026 – 11 year history

Nested row level

Base Level

Reporting Type

Standalone

Cell Data

Actual

Table Settings

YoY & New to Old

CAGR Columns

Select...

Nested row level

Base Level

Export

NEGATIVE
Cash From Operating Activity Biocon Mar-2026 Cash From Operating Activity is Rs -180 Cr which is growth of -128.9% YoY.
NEGATIVE
Net Cash Flow Biocon Mar-2026 Net Cash Flow is Rs -160 Cr which is growth of -225.9% YoY.

Biocon Ltd., Cash Flow, standalone, All financials are in INR Cr and price data in INR
Indicator	CAGR 3 Yrs	CAGR 5 Yrs	Mar '26	Mar '25	Mar '24	Mar '23	Mar '22	Mar '21	Mar '20	Mar '19	Mar '18	Mar '17	Mar '16
CFO_A Cash from Operating Act. Ann. ⌄	-	-	-180.1	623.9	-123.2	219.3	47.6	478.4	387.1	109.5	355.2	185.8	208.5
PBT_A PBT Ann.	-74.2%	-32.3%	51	660.9	150.3	2,971.2	139.7	358.8	548.2	552.1	305.8	536.2	559.4
INT_A Interest Ann.	27%	223.8%	142.4	236.9	198.8	69.6	0.4	0.4	1.2	2.6	1	3.8	1.9
TAX_A Tax Ann.	-51.7%	-29.3%	13.8	51.6	31	122.8	53.6	78.3	111.9	59.4	67.3	16.9	190.8
CFI_A Cash from Investing Act. Ann.	-	-	-6,581.7	-991.8	-296.4	-1,177.8	-305.6	-618.3	-212.9	310.9	-555.5	110.4	-321.1
CFA_A Cash from Financing Act. Ann.	85.2%	198.6%	6,602	494.8	343.6	1,039.4	112	27.8	-128.9	-208.2	-54.6	-238.3	73
NCF_A Net Cash Flow Ann. ⌄	-	-	-159.8	126.9	-76	80.9	-146	-112.1	45.3	212.2	-254.9	57.9	-39.6
CashAndCashEquivalentBeginOfYear_A Cash Plus Cash Eqv. Begin Of Year Ann.	31%	-7.8%	249.5	122.3	196.6	111	253.5	375	305.7	89.1	341.6	290.1	321.9
CashAndCashEquivalentEndOfYear_A Cash Plus Cash Eqv. End Of Year Ann.	-22.5%	-18.5%	91.4	249.5	122.3	196.6	111	253.5	375	305.7	89.1	341.6	290.1

*All financials are in INR Cr and price data in INR

Add metric to table

Search...

Cash from Financing Act. Ann.

1Y CHG

1234.3%

2Y CAGR

338.3%

3Y CAGR

85.2%

5Y CAGR

198.6%

10Y CAGR

56.9%

Cash from Financing Annual Activity growth is higher than historical averages.

Biocon investor presentations, annual reports, credit ratings, and earnings calls with AI summary, video, and audio access

Forecaster
Quarterly
Competitors/Peers
Revenue Mix
Annual
Balance Sheet
Ratios
Cash Flow
Documents

Biocon quarterly and annual financials: results, revenue, profit, P&L, balance sheet, cash flow, financial ratios, revenue mix, peer comparison, and financial documents

Biocon - Forecaster

Forecaster Analyst Estimates for Biocon share price target, revenues, EPS, net income and more